Skip to main content
Premium Trial:

Request an Annual Quote

FDA Clears Zymo Research Coronavirus Sample Collection Device

NEW YORK — Zymo Research said on Thursday that it has received 510(k) clearance from the US Food and Drug Administration for its DNA/RNA Shield Collection Tube, allowing its use for SARS-CoV-2 testing.

According to Zymo, the product consists of a tube filled with proprietary transport medium that stabilizes SARS-CoV-2 RNA for up to 28 days at ambient temperatures. The tube may be kitted with a swab or sputum collection kit, the company said.

Last year, Irvine, California-based Zymo received CE-IVD marking for the DNA/RNA Shield Collection Tube, as well as two other sample collection devices.

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.